Abstract: A fabric made by the method of providing a non-woven batt having flame retardant fibers, stitch bonding the non-woven batt with an elastic yarn, and heat setting the stitch bonded, non-woven batt. The stitch bonded non-woven batt is exposed to a temperature in a range of 160° C. to 200° C. for a period in a range of 30 seconds to 120 seconds. In an embodiment, the fabric is adapted for use as a mattress core cover.

Abstract: The present invention provides a composition which comprises the following Thyroid Stimulating Hormone Receptor (TSHR) peptides: (i) all or part of the amino acid sequence KKKKYVSIDVTLQQLESHKKK (SEQ ID NO: 1), or a part thereof, or a sequence having at least 60% sequence identity to SEQ ID NO:1; and (ii) all or part of the amino acid sequence GLKMFPDLTKVYSTD (SEQ ID NO: 2), or a part thereof, or a sequence having at least 60% sequence identity to SEQ ID NO:2. The present invention also relates to the use of such a composition for the prevention or suppression of activating autoantibody formation in Graves' disease.

Abstract: A fabric made by the method of providing a non-woven batt having flame retardant fibers, stitch bonding the non-woven batt with an elastic yarn, and heat setting the stitch bonded, non-woven batt. The stich bonded non-woven batt is exposed to a temperature in a range of 65° C. to 200° C. for a period in a range of 30 seconds to 120 seconds.

Abstract: The invention provides genetic constructs and recombinant vectors comprising such constructs. The constructs and vectors can be used in gene therapy methods for the treatment, prevention or amelioration of a neurodegenerative disorder, including Alzheimer's disease, Parkinson's disease, Huntington's disease, motor neurone disease, or for the treatment of stroke, or for promoting nerve regeneration and/or survival.

Abstract: The present invention relates to a therapeutic method using a tolerogenic peptide. In particular, the invention relates to a dosage regimen fora tolerogenic peptide. The therapeutic method can be used to treat or prevent conditions associated with aberrant, hypersensitivityor pathological immune responses to endogenous or exogenous proteins that results in a loss of immune tolerance.

Abstract: The invention provides genetic constructs and recombinant vectors comprising such constructs. The constructs and vectors can be used in gene therapy methods for treating a range of disorders, including glaucoma and deafness, or for promoting nerve regeneration and/or survival.

Abstract: An automatic transmission multi-mode clutch module (10, 100) may include either two concentric (30B, 30A) or two axially (130B, 130A) spaced sets of pawls (30B, 130B, 30A, 130A) nested between a pair of inner (20, 120) and outer races (12, 112). A first set of pawls (30B, 130B) is secured to the outer race (12, 112), and may be selectively released from a normally spring-biased default engagement with the inner race (20, 120) by an actuator cam ring (16, 116) rotatable between two angular limits. A second set of pawls (30A, 130A) is secured to the inner race (20, 120), and is released from a normally spring-biased default engagement with the outer race (12, 112) whenever the inner race (20, 120) reaches a threshold rotational speed, at which centrifugal forces acting on the inner set of pawls (30A, 130A) overcome the default spring bias to disengage the pawls (30A, 130A) from the outer race (12, 112).

Abstract: The present invention relates to a composition which comprises peptides derived from S-Arrestin (retinal arrestin, S-antigen, S-Ag). The composition or peptides may be useful in the prevention and/or suppression of S-Ag autoimmunity, which is useful in the treatment and/or prevention of uveitis.

Abstract: The present invention relates to a composition comprising a peptide derived from myelin basic protein (MBP) peptide for use in treating or preventing uveitis in a subject

Abstract: Various embodiments of the present invention relate generally to systems and methods for analyzing and manipulating images and video. In particular, a multi-view interactive digital media representation (MVIDMR) of an object can be generated from live images of an object captured from a camera. After the MVIDMR of the object is generated, a tag can be placed at a location on the object in the MVIDMR. The locations of the tag in the frames of the MVIDMR can vary from frame to frame as the view of the object changes. When the tag is selected, media content can be output which shows details of the object at location where the tag is placed. In one embodiment, the object can be car and tags can be used to link to media content showing details of the car at the locations where the tags are placed.

Abstract: A fabric made by the method of providing a non-woven batt having flame retardant fibers, stitch bonding the non-woven batt with an elastic yarn, and heat setting the stitch bonded, non-woven batt. The stich bonded non-woven batt is exposed to a temperature in a range of 65° C. to 200° C. for a period in a range of 30 seconds to 120 seconds.

Abstract: Various embodiments of the present invention relate generally to systems and methods for analyzing and manipulating images and video. In particular, a multi-view interactive digital media representation (MVIDMR) of an object can be generated from live images of an object captured from a camera. After the MVIDMR of the object is generated, a tag can be placed at a location on the object in the MVIDMR. The locations of the tag in the frames of the MVIDMR can vary from frame to frame as the view of the object changes. When the tag is selected, media content can be output which shows details of the object at location where the tag is placed. In one embodiment, the object can be car and tags can be used to link to media content showing details of the car at the locations where the tags are placed.

Abstract: An in vitro method for diagnosing a urological cancer comprising the comparison of a secretome of isolated cells from a urine sample from a patient to be diagnosed with respect: either to a reference secretome obtained from secretions of healthy isolated cells from a urine sample from a healthy person, or to a reference secretome obtained from secretions of healthy cells which are derivatives of standard cell line cultures, characteristic of a determined urological organ, the secretome and the reference secretome being constituted of all the components forming the respective secretions thereof.

Abstract: The invention provides genetic constructs and recombinant vectors comprising such constructs. The constructs and vectors can be used in gene therapy methods for treating a range of disorders, including glaucoma and deafness, or for promoting nerve regeneration and/or survival.

Abstract: Controlling foam in apparatus downstream of a melter by adjustment of alkali oxide content in the melter. One method includes feeding a feedstock into a submerged combustion melter (SCM) apparatus having an internal space containing a flowing or non-flowing molten mass of foamed glass comprising molten glass and bubbles entrained therein, the molten mass having glass foam comprising glass foam bubbles on at least a portion of a top surface of the molten mass. The molten mass from the SCM is routed to a downstream apparatus, stability of the glass foam in the downstream apparatus is observed, and alkali oxide percentage fed to the SCM apparatus is adjusted based on the observation to positively or negatively affect the foam stability. Systems for carrying out the methods, and the products of the methods are also considered novel and inventive.

Abstract: A microfluidic cell culture chip which contains a central module comprising a central unit, which contains a support consisting of a non-resorbable membrane, a 3D nanostructured porous membrane, comprising at least one protuberance, and the 3D nanostructured porous membrane and that at least one protuberance being composed of materials suitable for the culture of two distinct cell types; a base, and the central unit being integrated in the base, and forming a whole with the base.

Abstract: A flame-retardant fabric comprises a textile substrate having a layer of a nanoclay material extending along a surface of the textile substrate and integrated with the textile substrate.

Abstract: In an all-wheel drive (AWD) vehicle (10, 42), torque carrying connections are provided between the powertrain and all four wheels (12, 14, 22, 24). A multimode clutch module (50, 170) or clutches are provided to selectively disconnect two of the wheels (12, 14, 22, 24) from the powertrain during operating conditions where disconnection improves the performance and efficiency of the AWD vehicle (10, 42). The multimode clutch module (50, 170) may be installed at various locations of the AWD vehicle (10, 42), such as within a front or rear differential (20, 30), between a half axle (16, 18, 26, 28) and a differential (20, 30) or between a half axle (16, 18, 26, 28) and a corresponding wheel (12, 14, 22, 24), or within a transfer case (36) or power transfer unit (44).

Abstract: The present invention, in embodiments, is a fitted mattress core covering having a non-woven fabric comprising a plurality of flame-retardant fibers and elastic piping located along an edge of the non-woven fabric. The non-woven fabric, in embodiments, is substantially free of fiberglass, and the fitted mattress core covering is configured to fit over a mattress core such that the elastic piping extends underneath the mattress core when the fitted mattress core covering fits over the mattress core.

Abstract: An alert source issues security alerts to an identity provider, which acts as a gatekeeper to a secure resource. Each security alert is associated with an alert user identity and a security threat. When a user identity requests access to the secure resource, the identity provider may look up security alerts associated with the user identity, such as by matching up the user identity with the alert user identity associated with each alert. Based on any discovered security alerts that correspond to the user identity and a pre-defined security policy, the identity provider may perform various security actions on the user identity. The identity provider may provide access to the secure resource without containing the user identity if there are no discovered security alerts associated with the user identity, or if the discovered security alerts pose a minor threat.